Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole effect on QT interval in healthy volunteers
NCT02262546Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2007
- Primary completion
- Oct 2007
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of pramipexole in Parkinson's disease (PD) and restless legs syndrome (RLS), sponsored by Boehringer Ingelheim. Started May 2007; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT02262546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02262546.